|
PNRR - IIH IRST INNOVATION HUB
|
|
EU HE - MISSION CANCER | IMPACT-AML Master framework and pragmatic clinical trial for relapse or refractory acute myeloid leukemia
|
|
PNRR POC -Implementation of a predictive biomarker of response to regorafenib in glioblastoma
|
|
PNRR POC - TRUST Engineered lisyl oxidase lipid-based nanovesicles for the treatment of solid tumors: on the path to clinical application
|
|
PNRR POC - EVOLUTION Development and validation of a biomedical device for the detection, characterization and removal of Circulating Tumor Cells from the peripheral blood of patients for the treatment and diagnosis of cancer
|
|
PNRR POC - FUSION-TARGET A multi-omic approach for gene fusion detection in hematological malignancies: towards improved diagnostic screening and therapeutic targeting
|
|
PNRR - Life Science Hub for Advanced Therapies – LSH-TA National integrated system for implementing academic gene therapy/genome editing approaches aimed at treating inherited disorders
|
|
PNRR - PerfeTTO Technology Transfer Office Network in Life Science
|
|
EU 4 HEALTH - JANE Network of expertise on Cancer
|
|
EU HE - FLUTE Federate Learning and mUlti-party computation Techniques prostatE cancer
|
|
EU HE - ONCOVALUE Implementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time
|
|
EU HE EUROATOM - SECURE Strengthening the European chain of supply for next generation medical radionuclides
|
|
EU HE - TRUMPET TRUstworthy Multi-site Privacy Enhancing Technologies
|
